FI50831B - - Google Patents

Info

Publication number
FI50831B
FI50831B FI1089/69A FI108969A FI50831B FI 50831 B FI50831 B FI 50831B FI 1089/69 A FI1089/69 A FI 1089/69A FI 108969 A FI108969 A FI 108969A FI 50831 B FI50831 B FI 50831B
Authority
FI
Finland
Application number
FI1089/69A
Other languages
Finnish (fi)
Other versions
FI50831C (fi
Inventor
Garland Richard Brown
Original Assignee
Garland Richard Brown
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Garland Richard Brown filed Critical Garland Richard Brown
Publication of FI50831B publication Critical patent/FI50831B/fi
Application granted granted Critical
Publication of FI50831C publication Critical patent/FI50831C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/12—Magnesium silicate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FI691089A 1968-04-18 1969-04-15 Menetelmä korkean tehoainepitoisuuden omaavan antasidipreparaatin valm istamiseksi. FI50831C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72217668A 1968-04-18 1968-04-18
US78572768A 1968-12-20 1968-12-20

Publications (2)

Publication Number Publication Date
FI50831B true FI50831B (fr) 1976-04-30
FI50831C FI50831C (fi) 1976-08-10

Family

ID=27110553

Family Applications (1)

Application Number Title Priority Date Filing Date
FI691089A FI50831C (fi) 1968-04-18 1969-04-15 Menetelmä korkean tehoainepitoisuuden omaavan antasidipreparaatin valm istamiseksi.

Country Status (15)

Country Link
JP (1) JPS4621672B1 (fr)
AU (1) AU438147B2 (fr)
BE (1) BE731695A (fr)
CA (1) CA959760A (fr)
CH (1) CH536114A (fr)
DE (1) DE1919802A1 (fr)
DK (1) DK127269B (fr)
ES (1) ES366173A1 (fr)
FI (1) FI50831C (fr)
FR (1) FR2007475A1 (fr)
GB (1) GB1269987A (fr)
IL (1) IL32020A (fr)
NL (1) NL6906087A (fr)
NO (1) NO129077B (fr)
SE (1) SE388356B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1401257A (en) * 1972-06-30 1975-07-16 Miles Lab Process for preparing a spray dried calcium carbonate composition
GB1601833A (en) * 1978-02-06 1981-11-04 Wellcome Found Antacid formulation
SE7905972L (sv) * 1979-07-09 1981-01-10 Haessle Ab Forfarande for framstellning av magsyraneutraliserande medel, magsyraneutraliserande medel, samt metod for behandling av hyperaciditet och dermed relaterande sjukdomstillstand
SG72632A1 (en) * 1985-04-18 2000-05-23 Procter & Gamble Treatment of non-ulcer dyspepsia with bismuth salts
IT1215332B (it) * 1987-01-12 1990-02-08 Crinos Industria Farmaco Composizione farmaceutica contenente sulglicotide per la terapia dell'ulcera gastrica
DE3812378A1 (de) * 1988-04-14 1989-10-26 Theo Mertens Mobile erntegutmahl- und -mischvorrichtung
US4988679A (en) * 1989-01-03 1991-01-29 Leonard Chavkin Liquid sustained release composition
US4980175A (en) * 1989-01-03 1990-12-25 Leonard Chavkin Liquid orally administrable compositions based on edible oils
DE4305919A1 (de) * 1993-02-26 1994-09-01 Ruediger Potthoff Transportsilo für Kunststoff-Granulat
WO2003066022A2 (fr) * 2002-02-04 2003-08-14 Pharmacia Corporation Preparation pharmaceutique stable pour le traitement des troubles gastro-intestinaux
AU2003211627A1 (en) * 2002-03-04 2003-09-16 Medrx Co., Ltd. Liquid matrix undergoing phase transfer in vivo and liquid oral preparations
US20030232092A1 (en) * 2002-06-14 2003-12-18 Hasenmayer Donald L. Liquid antacid compositions
AU2015253187B2 (en) 2014-04-29 2017-10-05 The Procter & Gamble Company Method for making bismuth-containing liquid pharmaceutical suspensions
US9486460B2 (en) 2014-04-29 2016-11-08 The Procter & Gamble Company Bismuth containing liquid pharmaceutical suspensions
CN114732828A (zh) * 2022-04-27 2022-07-12 广西南宁百会药业集团有限公司 一种铝碳酸镁混悬液及其制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE621147A (fr) *

Also Published As

Publication number Publication date
SE388356B (sv) 1976-10-04
AU438147B2 (en) 1973-07-18
ES366173A1 (es) 1971-04-01
DK127269B (da) 1973-10-15
CA959760A (en) 1974-12-24
IL32020A0 (en) 1969-06-25
BE731695A (fr) 1969-10-20
NL6906087A (fr) 1969-10-21
GB1269987A (en) 1972-04-12
FR2007475A1 (fr) 1970-01-09
JPS4621672B1 (fr) 1971-06-19
IL32020A (en) 1972-11-28
NO129077B (fr) 1974-02-25
FI50831C (fi) 1976-08-10
DE1919802A1 (de) 1969-11-06
CH536114A (fr) 1973-04-30
AU5353969A (en) 1970-10-22

Similar Documents

Publication Publication Date Title
AU1946070A (fr)
AU428130B2 (fr)
AU2374870A (fr)
FI50831B (fr)
AU416157B2 (fr)
AU429879B2 (fr)
AU2581067A (fr)
AU421558B1 (fr)
AU2580267A (fr)
AR203075Q (fr)
AU3224368A (fr)
AU3789668A (fr)
AU4744468A (fr)
AU463027A (fr)
BE724389A (fr)
AU4224469A (fr)
AU3083868A (fr)
AU2889368A (fr)
AU4464266A (fr)
AU4503667A (fr)
AU4558658A (fr)
AU2496167A (fr)
BE728227A (fr)
BE727947A (fr)
BE727606A (fr)